Memorial Sloan-Kettering Cancer Center
Memorial Sloan Kettering AI spinout Partners with a Fortune 500 Company to Advance AI-powered Cancer Diagnosis
2021-05-28
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19